MX2022004065A - Preparacion de 2-cloro-1-(2-clorotiazol-5-il)etanona. - Google Patents

Preparacion de 2-cloro-1-(2-clorotiazol-5-il)etanona.

Info

Publication number
MX2022004065A
MX2022004065A MX2022004065A MX2022004065A MX2022004065A MX 2022004065 A MX2022004065 A MX 2022004065A MX 2022004065 A MX2022004065 A MX 2022004065A MX 2022004065 A MX2022004065 A MX 2022004065A MX 2022004065 A MX2022004065 A MX 2022004065A
Authority
MX
Mexico
Prior art keywords
chlorothiazol
ethanone
chloro
preparation
relates
Prior art date
Application number
MX2022004065A
Other languages
English (en)
Inventor
Christopher Koradin
Martin John Mclaughlin
Roland Goetz
Harish Shinde
Rahul Kaduskar
Sunil Khamkar
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of MX2022004065A publication Critical patent/MX2022004065A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de 2-cloro-1-(2-clorotiazol-5-il)etanon.
MX2022004065A 2019-10-04 2020-09-28 Preparacion de 2-cloro-1-(2-clorotiazol-5-il)etanona. MX2022004065A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19201400 2019-10-04
EP19204737 2019-10-23
PCT/EP2020/077090 WO2021063880A1 (en) 2019-10-04 2020-09-28 Preparation of 2-chloro-1-(2-chlorothiazol-5-yl)ethanone

Publications (1)

Publication Number Publication Date
MX2022004065A true MX2022004065A (es) 2022-05-02

Family

ID=72811793

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004065A MX2022004065A (es) 2019-10-04 2020-09-28 Preparacion de 2-cloro-1-(2-clorotiazol-5-il)etanona.

Country Status (11)

Country Link
US (1) US20240051929A1 (es)
EP (1) EP4038056B1 (es)
KR (1) KR20220078585A (es)
CN (1) CN114555568A (es)
AU (1) AU2020360778A1 (es)
BR (1) BR112022002459A2 (es)
CA (1) CA3146683A1 (es)
FI (1) FI4038056T3 (es)
IL (1) IL291873A (es)
MX (1) MX2022004065A (es)
WO (1) WO2021063880A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115845818B (zh) * 2022-12-13 2024-02-23 南京工业大学 一种木质素接枝n-[(二甲氨基)亚甲基]硫脲型重金属吸附剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1240436A (zh) * 1996-12-20 2000-01-05 拜尔公司 2－氯－5－氨甲基噻唑的制备方法
DE19908447A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Verfahren zur Herstellung von 2-Chlor-5-chlormethylthiazol
US20140278907A1 (en) 2013-03-13 2014-09-18 Microsoft Corporation Rewarding User Generated Content
EP3331893B1 (en) * 2015-08-05 2019-05-22 Enterome Mannose derivatives useful for treating pathologies associated with adherent e. coli
CN105348216A (zh) * 2015-11-09 2016-02-24 济南悟通化学科技有限公司 一种2-乙酰基噻唑的合成方法
RU2765370C2 (ru) * 2017-03-31 2022-01-28 Басф Се Соединения пиримидиния и их смеси для подавления животных-вредителей
MX2019012815A (es) * 2017-04-27 2020-01-14 Basf Se Proceso para la preparacion de compuestos de 2,3-dihidrotiazolo[3, 2-a]pirimidin-4-io opticamente activo.
WO2018202654A1 (en) * 2017-05-03 2018-11-08 Basf Se Process for preparing chiral 2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium compounds
WO2020058010A1 (en) * 2018-09-19 2020-03-26 Basf Se Pesticidal mixtures comprising a mesoionic compound

Also Published As

Publication number Publication date
US20240051929A1 (en) 2024-02-15
CA3146683A1 (en) 2021-04-08
FI4038056T3 (fi) 2024-01-31
WO2021063880A1 (en) 2021-04-08
CN114555568A (zh) 2022-05-27
EP4038056A1 (en) 2022-08-10
EP4038056B1 (en) 2023-11-08
IL291873A (en) 2022-06-01
BR112022002459A2 (pt) 2022-05-03
KR20220078585A (ko) 2022-06-10
AU2020360778A1 (en) 2022-04-14

Similar Documents

Publication Publication Date Title
EA202190983A1 (ru) Новое антитело к с-kit
PH12018500034A1 (en) Bicyclic lactams and methods of use thereof
MX2017014351A (es) Un proceso para la preparacion de epoxido de terpinoleno.
MX2019010769A (es) Proceso para la preparacion de enlazadores de farmacos de glucuronidos y compuestos intermediarios de los mismos.
MX2019006609A (es) Polvo de acero inoxidable para producir acero inoxidable sinterizado duplex.
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
MX2021003070A (es) Un proceso de fabricación de compuestos heterocíclicos de 2-nitroimino.
PH12021550102A1 (en) Cardiosafe antidiabetic therapy
MX2017003301A (es) Producto refractario, relleno para fabricar el producto, procedimiento para fabricar el producto y uso del producto refractario.
MX2018011877A (es) Proceso mejorado para la preparacion de tartrato de butorfanol.
MX2019001465A (es) Metodo de produccion de cetoenoles ciclicos sustituidos con espirocetales.
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
MX2017009698A (es) Composiciones de inmunoglobulina equina y usos para tratar enfermedades mediadas por filovirus.
ZA201903192B (en) Use of an acid treatment to decrease the plasticity of a composition comprising a titanium-containing zeolitic material having framework type mww
MX2022004065A (es) Preparacion de 2-cloro-1-(2-clorotiazol-5-il)etanona.
JOP20220119A1 (ar) أجسام مضادة trem2 واستخداماتها
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
IL279168B (en) A process for the preparation of eribulin
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
MX2021008323A (es) Preparacion de 5-aril pentanoles.
MX2021004996A (es) Preparacion de 4-metiltetrahidropiranos 2-sustituidos a partir de 4-hidroxi-4-metiltetrahidropiranos 2-sustituidos como materiales de partida.
MX2020013380A (es) Producto refractario, una mezcla para la fabricacion del producto, un procedimiento para la fabricacion del producto asi como un uso del producto.
MX2017002093A (es) Terapia con anticuerpos para vih como sustituto de tratamiento.
EA201691465A1 (ru) Средство для лечения сердечно-сосудистых заболеваний